Quarterly Report • Aug 3, 2017
Quarterly Report
Open in ViewerOpens in native device viewer
For the month of August, 2017
Commission File Number: 001-13742
(Exact name of registrant as specified in its charter)
Israel Chemicals Ltd. Millennium Tower 23 Aranha Street P.O. Box 20245 Tel Aviv, 61202 Israel (972-3) 684-4400 (Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes No
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes No
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333- 205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

| June 30, 2017 | June 30, 2016 | December 31, 2016 |
|
|---|---|---|---|
| \$ millions | \$ millions | \$ millions | |
| Current assets | |||
| Cash and cash equivalents | 79 | 158 | 87 |
| Short-term investments and deposits | 66 | 84 | 29 |
| Trade receivables | 930 | 980 | 966 |
| Inventories | 1,276 | 1,361 | 1,267 |
| Assets held for sale | 122 | 10 | - |
| Other receivables | 227 | 314 | 222 |
| Total current assets | 2,700 | 2,907 | 2,571 |
| Non-current assets | |||
| Investments in equity-accounted investees | 31 | 154 | 153 |
| Financial assets available for sale | 208 | 255 | 253 |
| Deferred tax assets | 148 | 150 | 150 |
| Property, plant and equipment | 4,419 | 4,294 | 4,309 |
| Intangible assets | 844 | 1,265 | 824 |
| Other non-current assets | 362 | 298 | 292 |
| Total non-current assets | 6,012 | 6,416 | 5,981 |
| Total assets | 8,712 | 9,323 | 8,552 |
| Current liabilities | |||
| Short-term credit | |||
| Trade payables | 782 717 |
495 753 |
588 644 |
| Provisions | 81 | 48 | 83 |
| Other current liabilities | 605 | 615 | 708 |
| Total current liabilities | 2,185 | 1,911 | 2,023 |
| Non-current liabilities | |||
| Long-term debt and debentures | |||
| Deferred tax liabilities | 2,663 302 |
3,187 265 |
2,796 303 |
| Long-term employee provisions | 639 | 582 | 576 |
| Provisions | 179 | 128 | 185 |
| Other non-current liabilities | 10 | 45 | 10 |
| Total non-current liabilities | 3,793 | 4,207 | 3,870 |
| Total liabilities | 5,978 | 6,118 | 5,893 |
| Equity | |||
| Total shareholders' equity | 2,656 | 3,077 | 2,574 |
| Non-controlling interests | 78 | 128 | 85 |
| Total equity | 2,734 | 3,205 | 2,659 |
| Total liabilities and equity | 8,712 | 9,323 | 8,552 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
(in millions except per share data)
| For the three-month For the six-month period ended period ended |
For the year ended |
||||
|---|---|---|---|---|---|
| June 30, 2017 |
June 30, 2016 |
June 30, 2017 |
June 30, 2016 |
December 31, 2016 |
|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Sales | 1,322 | 1,377 | 2,617 | 2,642 | 5,363 |
| Cost of sales | 907 | 960 | 1,844 | 1,859 | 3,703 |
| Gross profit | 415 | 417 | 773 | 783 | 1,660 |
| Selling, transport and marketing expenses | 183 | 179 | 363 | 334 | 722 |
| General and administrative expenses | 65 | 81 | 131 | 161 | 321 |
| Research and development expenses | 13 | 19 | 28 | 36 | 73 |
| Other expenses | 17 | 16 | 17 | 26 | 618 |
| Other income | (7) | (27) | (26) | (30) | (71) |
| Operating income (loss) | 144 | 149 | 260 | 256 | (3) |
| Finance expenses | 82 | 57 | 174 | 80 | 157 |
| Finance income | (33) | (17) | (111) | (12) | (25) |
| Finance expenses, net | 49 | 40 | 63 | 68 | 132 |
| Share in earnings of equity-accounted investees | 1 | 7 | 2 | 9 | 18 |
| Income (loss) before income taxes | 96 | 116 | 199 | 197 | (117) |
| Income taxes | 41 | 5 | 83 | 27 | 55 |
| Net income (loss) | 55 | 111 | 116 | 170 | (172) |
| Net loss attributable to the non-controlling interests | (2) | (9) | (9) | (16) | (50) |
| Net income (loss) attributable to the shareholders of the Company |
57 | 120 | 125 | 186 | (122) |
| Earnings (loss) per share attributable to the shareholders of the Company: |
|||||
| Basic earnings (loss) per share (in cents) | 4.48 | 9.00 | 9.78 | 15.00 | (10.00) |
| Diluted earnings (loss) per share (in cents) | 4.48 | 9.00 | 9.78 | 15.00 | (10.00) |
| Weighted-average number of ordinary shares outstanding: | |||||
| Basic (in thousands) | 1,274,666 | 1,272,949 | 1,274,432 | 1,272,949 | 1,273,295 |
| Diluted (in thousands) | 1,275,175 | 1,273,812 | 1,274,957 | 1,273,790 | 1,273,295 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| For the three-month For the six-month |
For the | ||||
|---|---|---|---|---|---|
| period ended | period ended | year ended | |||
| June 30, 2017 |
June 30, 2016 |
June 30, 2017 |
June 30, 2016 |
December 31, 2016 |
|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Net income (loss) | 55 | 111 | 116 | 170 | (172) |
| Components of other comprehensive income that will be reclassified subsequently to net income (loss) |
|||||
| Currency translation differences Changes in fair value of derivatives designated as a cash flow |
60 | (48) | 90 | - | (90) |
| hedge Changes in fair value of financial assets available for sale Tax income (expense) tax relating to items that will be reclassified |
- (36) |
- (5) |
- (51) |
(1) 8 |
(1) 17 |
| subsequently to net income (loss) | 1 | 1 | 5 | (2) | (5) |
| Total | 25 | (52) | 44 | 5 | (79) |
| Components of other comprehensive income that will not be reclassified to net income (loss) |
|||||
| Actuarial losses from defined benefit plan Income tax relating to items that will not be reclassified to net |
(5) | (27) | (9) | (46) | (48) |
| income (loss) | 1 | 3 | 2 | 9 | 8 |
| Total | (4) | (24) | (7) | (37) | (40) |
| Total comprehensive income (loss) | 76 | 35 | 153 | 138 | (291) |
| Comprehensive loss attributable to the non-controlling interests | - | (13) | (7) | (20) | (59) |
| Comprehensive income (loss) attributable to the shareholders of the Company |
76 | 48 | 160 | 158 | (232) |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| For the three-month period ended |
For the six-month period ended |
For the year ended |
|||
|---|---|---|---|---|---|
| June 30, 2017 |
June 30, 2016 |
June 30, 2017 |
June 30, 2016 |
December 31, 2016 |
|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Cash flows from operating activities | |||||
| Net income (loss) | 55 | 111 | 116 | 170 | (172) |
| Adjustments for: | |||||
| Depreciation and amortization | 95 | 99 | 189 | 198 | 406 |
| Revaluation of balances from financial institutions and interest | |||||
| expenses, net | 41 | 12 | 98 | 41 | 76 |
| Share in earnings of equity-accounted investees, net | (1) | (7) | (2) | (9) | (18) |
| Other capital losses (gains), net | (6) | 1 | (15) | 2 | 433 |
| Share-based compensation | 9 | 3 | 11 | 8 | 15 |
| Deferred tax expenses (income) | (6) | (49) | 7 | (54) | (2) |
| 187 | 170 | 404 | 356 | 738 | |
| Change in inventories | (4) | 57 | 24 | - | 70 |
| Change in trade and other receivables | 79 | (63) | 56 | 51 | 150 |
| Change in trade and other payables | (70) | 51 | (102) | 15 | (90) |
| Change in provisions and employee benefits | 7 | 23 | 12 | 38 | 98 |
| Net change in operating assets and liabilities | 12 | 68 | (10) | 104 | 228 |
| Net cash provided by operating activities | 199 | 238 | 394 | 460 | 966 |
| Cash flows from investing activities | |||||
| Investments in shares and proceeds from deposits, net | (28) | 2 | (38) | (247) | (198) |
| Purchases of property, plant and equipment and intangible assets | (113) | (154) | (219) | (341) | (632) |
| Proceeds from divestiture of subsidiaries | 6 | - | 6 | 17 | 17 |
| Dividends from equity-accounted investees | - | 1 | 3 | 4 | 12 |
| Other | - | 3 | 12 | (1) | 1 |
| Net cash used in investing activities | (135) | (148) | (236) | (568) | (800) |
| Cash flows from financing activities | |||||
| Dividend paid to the Company's shareholders | (89) | (102) | (149) | (102) | (162) |
| Receipt of long-term debt | 225 | 625 | 645 | 1,025 | 1,278 |
| Repayment of long-term debt | (350) | (484) | (775) | (734) | (1,365) |
| Short-term credit from banks and others, net | 152 | (91) | 116 | (84) | 14 |
| Other | - | - | - | - | (4) |
| Net cash provided by (used in) financing activities | (62) | (52) | (163) | 105 | (239) |
| Net change in cash and cash equivalents | 2 | 38 | (5) | (3) | (73) |
| Cash and cash equivalents as at beginning of the period | 81 | 123 | 87 | 161 | 161 |
| Net effect of currency translation on cash and cash equivalents | (4) | (3) | (3) | - | (1) |
| Cash and cash equivalents as at the end of the period | 79 | 158 | 79 | 158 | 87 |
| period ended | For the three-month | For the six-month period ended |
For the year ended |
||
|---|---|---|---|---|---|
| June 30, 2017 |
June 30, 2016 |
June 30, 2017 |
June 30, 2016 |
December 31, 2016 |
|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Income taxes paid, net of tax refunds | 17 | 16 | 38 | 52 | 84 |
| Interest paid | 34 | 37 | 55 | 53 | 112 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Attributable to the shareholders of the Company | Non controlling interests |
Total equity |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Cumulative | Treasury | Total | |||||||
| Share | Share | translation | Capital | shares, | Retained shareholders' | ||||
| capital premium adjustments reserves | at cost | earnings | equity | ||||||
| \$ millions | |||||||||
| For the three-month period ended June 30, 2017 |
|||||||||
| Balance as at April 1, 2017 | 544 | 174 | (451) | 70 | (260) | 2,526 | 2,603 | 78 | 2,681 |
| Share-based compensation | - | - | - | 9 | - | - | 9 | - | 9 |
| Dividends | - | - | - | - | - | (32) | (32) | - | (32) |
| Comprehensive income | - | - | 58 | (35) | - | 53 | 76 | - | 76 |
| Balance as at June 30, 2017 |
544 | 174 | (393) | 44 | (260) | 2,547 | 2,656 | 78 | 2,734 |
| Non controlling interests |
Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Cumulative Treasury Total |
|||||||||
| Share | Share | translation | Capital | shares, | Retained shareholders' | ||||
| capital premium adjustments reserves | at cost | earnings | equity | ||||||
| \$ millions | |||||||||
| For the three-month period ended June 30, 2016 |
|||||||||
| Balance as at April 1, 2016 | 544 | 150 | (352) | 91 | (260) | 2,888 | 3,061 | 153 | 3,214 |
| Share-based compensation | - | - | - | 3 | - | - | 3 | - | 3 |
| Dividends | - | - | - | - | - | (35) | (35) | - | (35) |
| Non-controlling interests in business combinations |
|||||||||
| from prior periods | - | - | - | - | - | - | - | (12) | (12) |
| Comprehensive income (loss) |
- | - | (44) | (4) | - | 96 | 48 | (13) | 35 |
| Balance as at June 30, 2016 |
544 | 150 | (396) | 90 | (260) | 2,949 | 3,077 | 128 | 3,205 |
| Attributable to the shareholders of the Company controlling |
Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Share | Share | Cumulative translation capital premium adjustments reserves |
Capital | Treasury shares, at cost |
earnings | Total Retained shareholders' equity |
|||
| For the six-month period ended June 30, 2017 Balance as at January 1, |
\$ millions | ||||||||
| 2017 Share-based compensation Dividends |
544 - - |
174 - - |
(481) - - |
79 11 - |
(260) - - |
2,518 - (89) |
2,574 11 (89) |
85 - - |
2,659 11 (89) |
| Comprehensive income (loss) |
- | - | 88 | (46) | - | 118 | 160 | (7) | 153 |
| Balance as at June 30, 2017 |
544 | 174 | (393) | 44 | (260) | 2,547 | 2,656 | 78 | 2,734 |
| Attributable to the shareholders of the Company | Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Cumulative | Treasury | Total | |||||||
| Share | Share | translation | Capital | shares, | Retained shareholders' | ||||
| capital premium adjustments reserves | at cost | earnings | equity | ||||||
| For the six-month period ended June 30, 2016 |
\$ millions | ||||||||
| Balance as at January 1, 2016 |
544 | 149 | (400) | 93 | (260) | 2,902 | 3,028 | 160 | 3,188 |
| Share-based compensation Dividends |
- - |
1 - |
- - |
7 - |
- - |
- (102) |
8 (102) |
- - |
8 (102) |
| Changes in equity of equity accounted investees |
- | - | - | (15) | - | - | (15) | - | (15) |
| Non-controlling interests in business combinations from prior periods |
- | - | - | - | - | - | - | (12) | (12) |
| Comprehensive income (loss) |
- | - | 4 | 5 | - | 149 | 158 | (20) | 138 |
| Balance as at June 30, 2016 |
544 | 150 | (396) | 90 | (260) | 2,949 | 3,077 | 128 | 3,205 |
| Attributable to the shareholders of the Company | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| controlling interests |
equity | ||||||||
| Cumulative | Treasury | Total | |||||||
| Share | Share | translation | Capital | shares, | Retained shareholders' | ||||
| capital premium adjustments reserves | at cost | earnings | equity | ||||||
| \$ millions | |||||||||
| For the year ended December 31, 2016 Balance as at January 1, |
|||||||||
| 2016 | 544 | 149 | (400) | 93 | (260) | 2,902 | 3,028 | 160 | 3,188 |
| Share-based compensation | - * | 25 | - | (10) | - | - | 15 | - | 15 |
| Dividends | - | - | - | - | - | (222) | (222) | (4) | (226) |
| Changes in equity of equity accounted investees |
- | - | - | (15) | - | - | (15) | - | (15) |
| Non-controlling interests in business combinations |
|||||||||
| from prior periods | - | - | - | - | - | - | - | (12) | (12) |
| Comprehensive loss | - | - | (81) | 11 | - | (162) | (232) | (59) | (291) |
| Balance as at December 31, 2016 |
544 | 174 | (481) | 79 | (260) | 2,518 | 2,574 | 85 | 2,659 |
* Less than \$1 million.
The accompanying notes are an integral part of these condensed consolidated financial statements.
Israel Chemicals Ltd. (hereinafter – the Company or ICL), is a leading global specialty minerals group that operates a unique, integrated business model.
ICL is a global manufacturer of products based on specialty minerals that fulfill humanity's essential needs in three primary markets: agriculture, food and engineered materials, by utilizing a unique, integrated business model.
The agricultural products produced by ICL help to feed the world's growing population. The potash and phosphates ICL mines and manufactures are used as ingredients in fertilizers and serve as an essential component in the pharmaceutical and food additives industries. ICL's bromine-based and phosphorous-based applications allow the safe and widespread use of a variety of products and materials, help to create energy that is more efficient and environmentally friendly and prevent the spread of forest fires. The food additives that ICL produces enable greater access to more varied and higher quality food.
ICL is a company domiciled and incorporated in Israel, the shares of which are traded on the Tel-Aviv Stock Exchange in Israel and on the New York Stock Exchange ("NYSE") in the United States. The Company's main shareholder is Israel Corporation Ltd.
The Company's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board (IASB) and the Company uses IFRS as its generally accepted accounting principles ("GAAP").
The condensed consolidated interim financial statements were prepared in accordance with IAS 34, "Interim Financial Reporting" and do not include all the information required in complete, annual financial statements. These condensed consolidated interim financial statements and notes are unaudited and should be read together with the Company's audited financial statements included in its Annual Report on Form 20-F as at and for the year ended December 31, 2016 (hereinafter – the Annual Financial Statements), as filed with the Securities and Exchange Commission ("SEC").
The accounting policies and assumptions used in preparation of these condensed consolidated interim financial statements are consistent with those used in preparation of the Company's Annual Financial Statements and in the Company's opinion include all the adjustments necessary to fairly present such information. Interim results are not necessarily indicative of the Company's expected results for the entire year.
ICL is a leading global specialty minerals company that operates a unique integrated business model. The Company operates via two segments: the Essential Minerals Segment and the Specialty Solutions Segment, which constitute the Company's strategic business segments.
Essential Minerals Segment – This segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and, since January 2017, also ICL Specialty Fertilizers. The comparative data has been restated in order to reflect the change. The segment targets the Agro market and focuses on efficiency, process innovation and operational excellence, in order to improve the competitive position.
ICL Potash & Magnesium – ICL Potash & Magnesium extracts potash from the Dead Sea and mines and produces potash and salt from subterranean mines in Spain and the UK. ICL Potash & Magnesium processes the potash into its types and markets it globally and also carries on other intercompany operations not solely related to the potash activities. The Company also mines and produces polysulphate (also known as polyhalite) in a subterranean mine in the UK. The magnesium business markets and sells pure magnesium and magnesium alloys, and also produces dry carnallite and related by-products, including chlorine and sylvinite.
ICL Phosphate – ICL Phosphate mines and processes phosphate rock from open pit mines – three of which are located in the Negev Desert in Israel while the fourth is situated in the Yunnan province in China. In addition, ICL Phosphate produces sulfuric acid, agricultural phosphoric acid and phosphate fertilizers in its facilities in Israel, China and Europe. Furthermore, ICL Phosphate manufactures phosphate-based food additives for livestock in Turkey. ICL Phosphate markets its products worldwide, mainly in Europe, Brazil, India and China.
ICL Specialty Fertilizers – ICL Specialty Fertilizers produces specialty fertilizers (e.g., water soluble) in the Netherlands and Belgium, liquid fertilizers and soluble fertilizers in Israel and Spain and controlled-release fertilizers in the Netherlands and the United States. ICL Specialty Fertilizers markets its products worldwide, mainly in Europe, North America and Israel.
Specialty Solutions Segment – This segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties. The segment targets industrial markets and concentrates on achieving growth through a highly-tailored customer focus, product innovation and commercial excellence.
ICL Industrial Products – ICL Industrial Products produces bromine out of a solution that is created as a by-product of the potash production process in Sodom, Israel, as well as bromine-based compounds. ICL Industrial Products uses most of the bromine it produces for self-production of bromine compounds at production sites in Israel, the Netherlands and China. In addition, ICL Industrial Products extracts from the Dead Sea potassium, salt, magnesium chloride and magnesia products used in the pharma, specialty steel, oil drilling, and oil additives industries, along with de-icing and other applications. In addition, ICL Industrial Products is engaged in the production and marketing of phosphorous-based flame retardants and additional phosphorus-based products.
ICL Advanced Additives – ICL Advanced Additives primarily develops, produces, markets and sells a broad range of acids and specialty phosphates for various applications in a large number of industries, including metal and water treatment, paints and coatings, forest fire retardants, cleaning materials, oral hygiene, carbonated drinks, asphalt modification and fuel additives. The diverse products and market base support and are consistent with the Company's strategy of increasing production of downstream products with higher added value. ICL Advanced Additives purifies some of the agricultural phosphoric acid manufactured by ICL Phosphate and also manufactures thermal phosphoric acid. The purified phosphoric acid and the thermal phosphoric acid are used to manufacture downstream products with high added value – phosphate salts and acids – which are used in the various industries mentioned above.
ICL Food Specialties – ICL Food Specialties is a leader in developing and producing functional food ingredients and phosphate additives, which provide texture and stability solutions for the processed meat, fish, dairy, beverage and baked-goods markets. In addition, the business line produces milk proteins and whey proteins for the food ingredient industry and provides blended, integrated solutions based on dairy proteins and phosphate additives. The business line operates primary production locations in Germany and Austria, which mainly process phosphates, milk and spices, and runs several local blending facilities in Germany, the UK, the United States, Brazil, China and Australia, enabling the production of "customer specific" solutions that meet the requirements of the local market.
The capital investments made by the segments, for each of the reporting periods, include mainly property, plant and equipment and intangible assets acquired in the ordinary course of business and as part of business combinations.
Segment revenues, expenses and results include inter-segment transfers, which are priced based on transaction prices in the ordinary course of business. These transfers are eliminated as part of consolidation of the financial statements. The segment income is measured based on the operating income, without certain expenses that are not allocated to the operating segments including general and administrative expenses, as it is included in reports that are regularly reviewed by the chief operating decision maker.
| Specialty Solutions |
Essential Minerals |
Other | |||
|---|---|---|---|---|---|
| Segment | Segment | Activities | Eliminations Consolidated | ||
| For the three-month period ended June 30, 2017 | \$ millions | ||||
| Sales to external parties Inter-segment sales Total sales |
625 15 640 |
687 49 736 |
10 1 11 |
- (65) (65) |
1,322 - 1,322 |
| Operating income attributed to segments General and administrative expenses Other unallocated expenses and intercompany eliminations Operating income |
135 | 81 | 1 | 217 (65) (8) 144 |
|
| Financing expenses, net Share in earnings of equity-accounted investee Income before taxes on income |
(49) 1 96 |
||||
| Capital expenditures Capital expenditures not allocated Total capital expenditures |
17 | 90 | 1 | 108 1 109 |
|
| Depreciation and amortization Depreciation and amortization not allocated Total depreciation and amortization |
27 | 66 | - | 93 2 95 |
| Specialty Solutions Segment |
Essential Minerals Segment |
Other Activities |
Eliminations Consolidated | ||
|---|---|---|---|---|---|
| \$ millions | |||||
| For the three-month period ended June 30, 2016 | |||||
| Sales to external parties Inter-segment sales Total sales |
655 12 667 |
709 56 765 |
13 - 13 |
- (68) (68) |
1,377 - 1,377 |
| Operating income (loss) attributed to segments General and administrative expenses Other unallocated expenses and intercompany eliminations Operating income |
136 | 113 | (2) | 247 (81) (17) 149 |
|
| Financing expenses, net Share in earnings of equity-accounted investee Income before taxes on income |
(40) 7 116 |
||||
| Capital expenditures Capital expenditures not allocated Total capital expenditures |
26 | 146 | 1 | 173 23 196 |
|
| Depreciation and amortization Depreciation and amortization not allocated Total depreciation and amortization |
28 | 70 | - | 98 1 99 |
| Specialty | Essential | ||||
|---|---|---|---|---|---|
| Solutions Segment |
Minerals Segment |
Other Activities |
Eliminations Consolidated | ||
| \$ millions | |||||
| For the six-month period ended June 30, 2017 | |||||
| Sales to external parties | 1,224 | 1,373 | 20 | - | 2,617 |
| Inter-segment sales | 29 | 97 | 2 | (128) | - |
| Total sales | 1,253 | 1,470 | 22 | (128) | 2,617 |
| Operating income attributed to segments General and administrative expenses Other unallocated expenses and intercompany eliminations Operating income |
250 | 147 | 1 | 398 (131) (7) 260 |
|
| Financing expenses, net Share in earnings of equity-accounted investee Income before taxes on income |
(63) 2 199 |
||||
| Capital expenditures Capital expenditures not allocated Total capital expenditures |
30 | 189 | 1 | 220 1 221 |
|
| Depreciation and amortization Depreciation and amortization not allocated Total depreciation and amortization |
55 | 131 | 1 | 187 2 189 |
| Specialty | Essential | ||||
|---|---|---|---|---|---|
| Solutions Segment |
Minerals Segment |
Other Activities |
Eliminations Consolidated | ||
| \$ millions | |||||
| For the six-month period ended June 30, 2016 | |||||
| Sales to external parties | 1,225 | 1,379 | 38 | - | 2,642 |
| Inter-segment sales | 26 | 109 | - | (135) | - |
| Total sales | 1,251 | 1,488 | 38 | (135) | 2,642 |
| Operating income attributed to segments General and administrative expenses Other unallocated expenses and intercompany eliminations Operating income |
242 | 206 | - | 448 (161) (31) 256 |
|
| Financing expenses, net Share in earnings of equity-accounted investee Income before taxes on income |
(68) 9 197 |
||||
| Capital expenditures Capital expenditures not allocated Total capital expenditures |
51 | 269 | 1 | 321 38 359 |
|
| Depreciation and amortization Depreciation and amortization not allocated Total depreciation and amortization |
54 | 143 | - | 197 1 198 |
| Specialty | Essential | ||||
|---|---|---|---|---|---|
| Solutions Segment |
Minerals Segment |
Other Activities |
Eliminations Consolidated | ||
| \$ millions | |||||
| For the year ended December 31, 2016 | |||||
| Sales to external parties | 2,493 | 2,811 | 59 | - | 5,363 |
| Inter-segment sales | 60 | 225 | - | (285) | - |
| Total sales | 2,553 | 3,036 | 59 | (285) | 5,363 |
| Operating income attributed to segments General and administrative expenses Other unallocated expenses and intercompany eliminations Operating loss |
534 | 398 | 5 | 937 (321) (619) (3) |
|
| Financing expenses, net Share in earnings of equity-accounted investee Loss before taxes on income |
(132) 18 (117) |
||||
| Capital expenditures Capital expenditures not allocated Total capital expenditures |
95 | 497 | 1 | 593 59 652 |
|
| Depreciation and amortization Depreciation and amortization not allocated Total depreciation and amortization |
106 | 292 | 3 | 401 5 406 |
| 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
|
| Specialty Solutions | ||||||||||
| Segment | ||||||||||
| Industrial Products | 291 | 22 | 294 | 21 | 601 | 23 | 562 | 21 | 1,120 | 21 |
| Advanced Additives | 208 | 16 | 206 | 15 | 377 | 14 | 369 | 14 | 798 | 15 |
| Food Specialties | 147 | 11 | 174 | 13 | 285 | 11 | 336 | 13 | 659 | 12 |
| 646 | 49 | 674 | 49 | 1,263 | 48 | 1,267 | 48 | 2,577 | 48 | |
| Essential Minerals Segment |
||||||||||
| Potash & Magnesium | 314 | 24 | 299 | 22 | 597 | 23 | 572 | 22 | 1,338 | 25 |
| Phosphate | 264 | 20 | 319 | 23 | 556 | 21 | 618 | 23 | 1,163 | 22 |
| Specialty Fertilizers | 190 | 14 | 189 | 14 | 382 | 15 | 377 | 14 | 661 | 12 |
| 768 | 58 | 807 | 59 | 1,535 | 59 | 1,567 | 59 | 3,162 | 59 | |
| Other and setoffs | (92) | (7) | (104) | (8) | (181) | (7) | (192) | (7) | (376) | (7) |
| Total | 1,322 | 100 | 1,377 | 100 | 2,617 | 100 | 2,642 | 100 | 5,363 | 100 |
| 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
|
| Europe | 457 | 34 | 480 | 35 | 991 | 38 | 1,039 | 39 | 1,863 | 35 |
| Asia | 325 | 25 | 320 | 23 | 607 | 23 | 559 | 21 | 1,275 | 24 |
| North America | 276 | 21 | 282 | 20 | 570 | 22 | 549 | 21 | 1,141 | 21 |
| South America | 194 | 15 | 177 | 13 | 292 | 11 | 269 | 10 | 588 | 11 |
| Rest of the world | 70 | 5 | 118 | 9 | 157 | 6 | 226 | 9 | 496 | 9 |
| Total | 1,322 | 100 | 1,377 | 100 | 2,617 | 100 | 2,642 | 100 | 5,363 | 100 |
| 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
|
| USA | 260 | 20 | 261 | 19 | 536 | 20 | 515 | 20 | 1,070 | 20 |
| Brazil | 176 | 13 | 159 | 11 | 253 | 10 | 236 | 9 | 521 | 10 |
| China | 158 | 12 | 153 | 11 | 303 | 12 | 261 | 10 | 669 | 12 |
| Germany | 93 | 7 | 108 | 8 | 191 | 7 | 220 | 8 | 392 | 7 |
| United Kingdom | 77 | 6 | 73 | 5 | 166 | 6 | 170 | 6 | 306 | 6 |
| Spain | 61 | 5 | 69 | 5 | 140 | 5 | 144 | 6 | 258 | 5 |
| India | 55 | 4 | 64 | 5 | 92 | 4 | 90 | 3 | 199 | 4 |
| France | 53 | 4 | 57 | 4 | 124 | 5 | 128 | 5 | 226 | 4 |
| Israel | 44 | 3 | 58 | 4 | 96 | 4 | 111 | 4 | 237 | 4 |
| Netherlands | 27 | 2 | 21 | 2 | 49 | 2 | 47 | 2 | 91 | 2 |
| All other | 318 | 24 | 354 | 26 | 667 | 25 | 720 | 27 | 1,394 | 26 |
| Total | 1,322 | 100 | 1,377 | 100 | 2,617 | 100 | 2,642 | 100 | 5,363 | 100 |
The carrying amounts of certain financial assets and financial liabilities, including cash and cash equivalents, investments, short-term deposits and loans, receivables and other debit balances, long-term investments and receivables, short-term credit, payables and other credit balances, long-term loans bearing variable interest and other liabilities, and derivative financial instruments, correspond to or approximate their fair value.
The following table details the book value and fair value of financial instrument groups presented in the financial statements not in accordance with their fair value:
| June 30, 2017 | June 30, 2016 | December 31, 2016 | ||||
|---|---|---|---|---|---|---|
| Carrying amount |
Fair value | Carrying amount |
Fair value | Carrying amount |
Fair value | |
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Loans bearing fixed interest | 229 | 238 | 339 | 355 | 293 | 306 |
| Debentures bearing fixed interest | ||||||
| Marketable | 1,242 | 1,289 | 1,200 | 1,238 | 1,201 | 1,201 |
| Non-marketable | 281 | 293 | 281 | 291 | 281 | 283 |
| 1,752 | 1,820 | 1,820 | 1,884 | 1,775 | 1,790 |
The following table presents an analysis of the financial instruments measured at fair value, using a valuation method in accordance with the fair value levels in the hierarchy.
Levels definitions:
Level 1: Quoted (unadjusted) prices in an active market for identical instruments.
Level 2: Observed data in the market (directly or indirectly) not included in Level 1 above.
Level 3: Inputs that are not based on observable market data.
| June 30, 2017 | ||||
|---|---|---|---|---|
| Level 2 | Level 3 | Total | ||
| \$ millions | \$ millions | \$ millions | ||
| Financial assets available for sale (1) | - | 208 | 208 | |
| Derivatives used for economic hedging, net | 71 | - | 71 | |
| 71 | 208 | 279 |
| June 30, 2016 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| \$ millions | \$ millions | \$ millions | \$ millions | |
| Securities held for trading purposes | 25 | - | - | 25 |
| Financial assets available for sale (1) | - | - | 255 | 255 |
| Derivatives used for economic hedging, net | - | (38) | - | (38) |
| 25 | (38) | 255 | 242 |
| December 31, 2016 | |||||
|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | ||
| \$ millions | \$ millions | \$ millions | \$ millions | ||
| Securities held for trading purposes | 10 | - | - | 10 | |
| Financial assets available for sale (1) | - | - | 253 | 253 | |
| Derivatives used for economic hedging, net | - | 7 | - | 7 | |
| 10 | 7 | 253 | 270 |
(1) Investment in 15% of the share capital of YTH, which is subject to a three-year lock-up period as required by Chinese law. Measurement of the fair value of the discount rate in respect of the lock-up period was calculated by use of the Finnerty 2012 Model and is based on an estimate of the period in which the restriction on marketability applies and a standard deviation of the yield on a YTH share in this period. The impact stemming from a possible and reasonable change in these data items, which are not observed, is not material.
| Grant date | Employees entitled |
Number of instruments (thousands) |
Issuance's details | Instrument terms |
Vesting conditions |
Expiration date |
|---|---|---|---|---|---|---|
| June 20, 2017, for Chairman of the BOD – August 2, 2017 the date of the approval of the General Meeting. |
Officers and Senior employees Chairman of BOD. |
6,966 165 |
An issuance of non marketable and non transferrable options, for no consideration, under the 2014 Equity Compensation Plan (amended) to 498 ICL officers and senior employees in Israel and overseas. |
Upon exercise, each option may be converted into one ordinary share of NIS 1 par value of the Company. |
3 equal tranches: (1) one third at the end of 12 months after the grant date (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date. |
7 years from the vesting date. |
| June 2017 Options Grant | |||
|---|---|---|---|
| Share price (in \$) | 4.49 | ||
| CPI-linked exercise price (in \$) | 4.29 | ||
| Expected volatility | 31.91% | ||
| Expected life of options (in years) | 7 | ||
| Risk-free interest rate | 0.38% | ||
| Total fair value (in \$ millions) | 11 | ||
| Dividend – exercise price | Reduced on the "ex-dividend" date by the amount of the dividend per share |
The options issued to the employees in Israel are covered by the provisions of Section 102 of the Israeli Income Tax Ordinance. The issuance will be performed through a trustee under the Capital Gains Track. The fair value of the options was estimated using the Black& Scholes model for pricing options. The exercise price is linked to the CPI that is known as of the date of payment, which is the exercise date. In a case of distribution of a dividend by the Company, the exercise price is reduced on the "ex dividend" date, by the amount of the dividend per share, based on the amount thereof in NIS on the effective date.
The expected volatility was determined on the basis of the historical volatility of the Company's share prices. The expected life of the options was determined on the basis of Management's estimate of the period the employees will hold the options, taking into consideration their position with the Company and the Company's past experience regarding the turnover of employees. The risk-free interest rate was determined on the basis of the yield to maturity of shekel-denominated Israeli Government debentures, with a remaining life equal to the anticipated life of the options.
The cost of the embedded benefits of the said plans will be recognized in the income statements over the vesting period of each tranche taking into account also the Company's policy relating "Rule75" (accelerated vesting period for employees which their age plus their years of employments in the Company exceed 75).
| Grant date | Employees entitled |
Number of instruments (thousands) |
Vesting conditions | Instrument terms |
Additional Information |
Fair value at the grant date (Million) |
|---|---|---|---|---|---|---|
| June 20, 2017, for Chairman of |
Officers and Senior employees |
2,233 | 3 equal tranches: (1) one third at the end of 12 months after the grant date |
An issuance for no consideration, |
The value of the restricted shares was determined |
10 |
| the BOD – August 2, 2017 the date of the approval of the General Meeting. |
Chairman of BOD. |
53 | (2) one third at the end of 24 months after the grant date (3) one third at the end of 36 months after the grant date. |
under the 2014 Equity Compensation Plan (amended) |
according to the closing price on the TASE on the most recent trading day preceding the grant date (the date approval of the BOD/General meeting) |
0.3 |
| Decision date for dividend distribution by the Board of Directors |
Actual date of dividend distribution |
Distributed amount (\$ millions) |
Dividend per share (\$) |
|---|---|---|---|
| November 22, 2016 | January 4, 2017 | 60 | 0.04701 |
| February 14, 2017 | April 4, 2017 | 57 | 0.04400 |
| May 9, 2017 | June 20, 2017 | 34 | 0.02600 |
| August 2, 2017 (after the date of the report)* | September 13, 2017 | 32 | 0.02450 |
(*) The dividend will be distributed on September 13, 2017, with a record date for eligibility for the dividend of August 29, 2017.
The Company is taking action to explore solutions for, among other things, restoration of the ponds in the short- and long-term and to rectify any environmental harm caused, to the extent required. The Company's actions are being carried out in full coordination and close cooperation with the Israeli environmental authorities, including the Ministry of Environmental Protection and the Nature and National Parks Authority. The Company is committed to environmental responsibility, and for years has worked closely with the Israeli's environmental authorities to maintain the Negev's natural reserves in the area of its facilities.
In light of the preliminary stages of the cost evaluation process, its complexity and the uncertainty regarding future resolutions and demands, the Company cannot estimate the expected restoration costs at this stage. Nevertheless, the Company recorded a provision, in an immaterial amount, which reflects the expenses that are expected to be incurred in the short term. The Company is in contact with its insurance carriers with reference to the relevant insurance policies regarding the matters described above.
The monetary remedy was not defined, however, according to the requesting parties, the amount of the personal claim is NIS 1,000 (\$283) for all residents of the State of Israel, which totals 8.68 million persons. In the framework of the second application, the Court is requested to grant a monetary remedy in an amount of not less than NIS 250 million (\$71 million), and concurrently to award personal compensation in the amount of NIS 2,000 (\$567) for all residents of the State of Israel, this being in respect of non-pecuniary damages. Furthermore, the Court was requested to instruct the Company to comply with the relevant laws and the rules provided thereunder.
In light of the very early stage of the proceeding and the limited number of similar court cases, it is difficult, at this stage, to predict the outcome of the applications.
In addition, in March 2017, the Supreme Court sitting as the High Court of Justice rejected the petition of residents of Arad against the policy document of the National Council for Planning and Building regarding the mining plan in the Barir field.

This announcement contains statements that constitute "forward-looking statements", many of which can be identified by the use of forward-looking words such as "anticipate'", "believe", "could", "expect", "should", "plan", "intend", "estimate" and "potential", among others.
Forward-looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward- looking statements due to various factors, including, but not limited to:
Loss or impairment of business licenses or mining permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and our reserve estimates; natural disasters; failure to raise the water level in evaporation Pond 5 in the Dead Sea; construction of a new pumping station; disruptions at our seaport shipping facilities or regulatory restrictions affecting our ability to export our products overseas; general market, political or economic conditions in the countries in which we operate; price increases or shortages with respect to our principal raw materials; delays in the completion of major projects by third party contractors and/or governmental obligations; construction of a canal between the Red Sea and Dead Sea; labor disputes, slowdowns and strikes involving our employees; pension and health insurance liabilities; changes to governmental programs or tax benefits, creation of new fiscal or tax related legislation; higher tax liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of our information technology systems or breaches of our data security; failure to recruit or maintain key personnel; inability to realize expected benefits from our cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of our businesses; changes in demand for our fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond our control; decreases in demand for bromine based products and other industrial products; volatility or crises in the financial markets; cost of compliance with environmental legislative and licensing restrictions; hazards inherent to chemical manufacturing, including the impact of the collapse of the dyke in Pond 3 in our Rotem Amfert facility; litigation, arbitration and regulatory proceedings; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror; and other risk factors discussed under "Item 3. Key Information—D. Risk Factors" in the company's Annual Report on Form 20-F filed with the U.S Securities and Exchange Commission on March 16, 2017.
Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update or revise them or any other information contained in this report, whether as a result of new information, future developments or otherwise. You are advised, however, to read any additional disclosures included in the Immediate Reports furnished by the Company to the SEC on Form 6-K.
We are a leading global specialty minerals company that operates a unique, integrated business model. We extract raw materials and utilize sophisticated processing and product formulation technologies to add value to customers in three attractive end-markets: agriculture, food and engineered materials. Our operations are organized under two segments: the Essential Minerals Segment and the Specialty Solutions Segment. The Essential Minerals Segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and ICL Specialty Fertilizers. The Specialty Solutions Segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties.
Our operations are organized under two segments: the Essential Minerals Segment and the Specialty Solutions Segment.
Essential Minerals Segment – This segment targets the Agro markets and focuses on efficiency, process innovation and operational excellence, in order to improve its competitive position. The segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and, since January 2017, also ICL Specialty Fertilizers. Management believes that operating ICL Specialty Fertilizers as part of the Essential Minerals segment is expected to create synergies given the homogenous business and customer bases of the segment's three business lines. Furthermore, the transfer expands the segment's portfolio to include a broader range of commodity, specialty and semi-specialty products. As a result, the comparative data has been restated in order to reflect the mentioned above change.
ICL Potash & Magnesium – ICL Potash & Magnesium extracts potash from the Dead Sea and mines and produces potash and salt from subterranean mines in Spain and the UK. ICL Potash & Magnesium processes the potash into its types and markets it globally and also carries on other intercompany operations not solely related to the potash activities. The Company also mines and produces polysulphate (also known as polyhalite) in a subterranean mine in the UK. The magnesium business markets and sells pure magnesium and magnesium alloys, and also produces dry carnallite and related by-products, including chlorine and sylvinite.
ICL Phosphate – ICL Phosphate mines and processes phosphate rock from open pit mines – three of which are located in the Negev Desert in Israel while the fourth is situated in the Yunnan province in China. In addition, ICL Phosphate produces sulfuric acid, agricultural phosphoric acid and phosphate fertilizers in its facilities in Israel, China and Europe. Furthermore, ICL Phosphate manufactures phosphate-based food additives for livestock in Turkey. ICL Phosphate markets its products worldwide, mainly in Europe, Brazil, India and China.
ICL Specialty Fertilizers – ICL Specialty Fertilizers produces specialty fertilizers (e.g., water soluble) in the Netherlands and Belgium, liquid fertilizers and soluble fertilizers in Israel and Spain, and controlled-release fertilizers in the Netherlands and the United States. ICL Specialty Fertilizers markets its products worldwide, mainly in Europe, North America and Israel.
Specialty Solutions Segment – This segment targets industrial markets and concentrates on achieving growth through a highly-tailored customer focus, product innovation and commercial excellence. The segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties.
ICL Industrial Products – ICL Industrial Products produces bromine out of a solution that is created as a by-product of the potash production process in Sodom, Israel, as well as bromine-based compounds. ICL Industrial Products uses most of the bromine it produces for self-production of bromine compounds at production sites in Israel, the Netherlands and China. In addition, ICL Industrial Products extracts from the Dead Sea potassium, salt, magnesium chloride and magnesia products used in the pharma, specialty steel, oil drilling, and oil additives industries, along with de-icing and other applications. In addition, ICL Industrial Products is engaged in the production and marketing of phosphorous-based flame retardants and additional phosphorus-based products.
ICL Advanced Additives – ICL Advanced Additives primarily develops, produces, markets and sells a broad range of acids and specialty phosphates for various applications in a large number of industries, including metal and water treatment, paints and coatings, forest fire retardants, cleaning materials, oral hygiene, carbonated drinks, asphalt modification and fuel additives. The diverse products and market base support and are consistent with the Company's strategy of increasing production of downstream products with higher added value. ICL Advanced Additives purifies some of the agricultural phosphoric acid manufactured by ICL Phosphate and also manufactures thermal phosphoric acid. The purified phosphoric acid and the thermal phosphoric acid are used to manufacture downstream products with high added value – phosphate salts and acids – which are used in the various industries mentioned above.
ICL Food Specialties – ICL Food Specialties is a leader in developing and producing functional food ingredients and phosphate additives, which provide texture and stability solutions for the processed meat, fish, dairy, beverage and baked goods markets. In addition, the business line produces milk proteins and whey proteins for the food ingredient industry and provides blended, integrated solutions based on dairy proteins and phosphate additives. The business line operates primary production locations in Germany and Austria, which mainly process phosphates, milk and spices, and runs several local blending facilities in Germany, the UK, the United States, Brazil, China and Australia, enabling the production of "customer specific" solutions that meet the requirements of the local market.
| 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| \$ | % of | \$ | % of | \$ | % of | \$ | % of | \$ | % of | |
| millions | sales | millions | sales | millions | sales | millions | sales | millions | sales | |
| Sales | 1,322 | - | 1,377 | - | 2,617 | - | 2,642 | - | 5,363 | - |
| Gross profit | 415 | 31 | 417 | 30 | 773 | 30 | 783 | 30 | 1,660 | 31 |
| Operating income (loss) | 144 | 11 | 149 | 11 | 260 | 10 | 256 | 10 | (3) | - |
| Adjusted operating income (1) | 153 | 12 | 163 | 12 | 269 | 10 | 278 | 11 | 582 | 11 |
| Net income (loss) - shareholders of | ||||||||||
| the Company | 57 | 4 | 120 | 9 | 125 | 5 | 186 | 7 | (122) | - |
| Adjusted net income - shareholders of | ||||||||||
| the Company (1) | 64 | 5 | 132 | 10 | 132 | 5 | 217 | 8 | 451 | 8 |
| Adjusted EBITDA (2) | 251 | 19 | 278 | 20 | 469 | 18 | 501 | 19 | 1,051 | 20 |
| Cash flows from operating activities | 199 | - | 238 | - | 394 | - | 460 | - | 966 | - |
| Capital expenditures | 109 | - | 196 | - | 221 | - | 359 | - | 652 | - |
(1) See "Adjustments to reported operating and net income" below.
(2) See "Adjusted EBITDA for the periods of activity" below.
Adjustments to reported operating and net income
| 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Operating income (loss) | 144 | 149 | 260 | 256 | (3) |
| Capital (gain) loss (1) | (6) | - | (6) | 1 | 1 |
| Write-down and impairment of assets (2) | - | - | - | - | 489 |
| Provision for early retirement and dismissal of employees (3) | 15 | - | 15 | 6 | 39 |
| Provision in respect of prior periods resulting from an arbitration | |||||
| decision (4) | - | - | - | - | 13 |
| Retroactive electricity charges (5) | - | - | - | - | (16) |
| Provision for legal claims (6) | - | 14 | - | 15 | 8 |
| Provision for historical waste removal (7) | - | - | - | - | 51 |
| Total adjustments to operating income (loss) | 9 | 14 | 9 | 22 | 585 |
| Adjusted operating income | 153 | 163 | 269 | 278 | 582 |
| Net income (loss) attributable to the shareholders of the Company |
57 | 120 | 125 | 186 | (122) |
| Total adjustments to operating income (loss) | 9 | 14 | 9 | 22 | 585 |
| Adjustments to finance expenses (8) | - | - | - | - | 38 |
| Total tax impact of the above operating income & finance | |||||
| expenses adjustments | (2) | (2) | (2) | (4) | (81) |
| Tax assessment and deferred tax adjustments (9) | - | - | - | 13 | 36 |
| Adjustments attributable to the non-controlling interests | - | - | - | - | (5) |
| Total adjusted net income - shareholders of the Company | 64 | 132 | 132 | 217 | 451 |
Calculation of adjusted EBITDA was made as follows:
| 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Net income (loss) attributable to the shareholders of | |||||
| the Company | 57 | 120 | 125 | 186 | (122) |
| Depreciation and amortization | 95 | 99 | 189 | 198 | 401 |
| Financing expenses, net | 49 | 40 | 63 | 68 | 132 |
| Taxes on income | 41 | 5 | 83 | 27 | 55 |
| Adjustments * | 9 | 14 | 9 | 22 | 585 |
| Total adjusted EBITDA | 251 | 278 | 469 | 501 | 1,051 |
* See "Adjustments to reported operating and net income" above.
We disclose in this Quarterly Report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating and net income" above. Certain of these items may recur. We calculate our adjusted net income attributable to the Company's shareholders by adjusting our net income attributable to the Company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating and net income" above, excluding the total tax impact of such adjustments and adjustments attributable to the non-controlling interests. We calculate our adjusted EBITDA by adding back to the net income attributable to the Company's shareholders the depreciation and amortization, financing expenses, net, taxes on income and the items presented in the reconciliation table under "Adjusted EBITDA for the periods of activity" above which were adjusted for in calculating the adjusted operating income and adjusted net income attributable to the Company's shareholders.
You should not view adjusted operating income, adjusted net income attributable to the Company's shareholders or adjusted EBITDA as a substitute for operating income or net income attributable to the Company's shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA may differ from those used by other companies. However, we believe adjusted operating income, adjusted net income attributable to the Company's shareholders and adjusted EBITDA provide useful information to both management and investors by excluding certain expenses that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management's performance. We believe that these non-IFRS measures provide useful information to investors because they improve the comparability of the financial results between periods and provide for greater transparency of key measures used to evaluate our performance.
We present a discussion in the period-to-period comparisons of the primary drivers of changes in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends in its businesses. We have based the following discussion on our financial statements. You should read the following discussion together with our financial statements.
Sales
| Sales analysis | \$ millions |
|---|---|
| Total sales Q2 2016 | 1,377 |
| Quantity | (21) |
| Price | (17) |
| Exchange rate | (17) |
| Total sales Q2 2017 | 1,322 |
The following table sets forth sales by geographical regions based on the location of the customer:
| 4-6/2017 | 4-6/2016 | ||||
|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
||
| Europe | 457 | 34 | 480 | 35 | |
| Asia | 325 | 25 | 320 | 23 | |
| North America | 276 | 21 | 282 | 20 | |
| South America | 194 | 15 | 177 | 13 | |
| Rest of the world | 70 | 5 | 118 | 9 | |
| Total | 1,322 | 100 | 1,377 | 100 |
The breakdown of the sales in the second quarter of 2017 shows a decrease in sales to Europe, deriving mainly from a decline in quantities and selling prices of potash, partly offset by an increase in sales of clear brine solutions and dairy proteins. The minor increase in sales to Asia derives mainly from an increase in quantities sold of potash and phosphoric acid, mostly offset by a decrease in phosphate fertilizers selling prices and quantities sold, together with a decrease in phosphate rock quantities sold. The sales to North America were stable compared to the corresponding quarter last year (with a minor reduction) despite the challenging business environment. The increase in sales to South America derives mainly from an increase in potash selling prices and quantities sold, partly offset by a decrease in phosphate fertilizers quantities sold. The decrease in sales to the rest of the world derives mainly from a decrease in the quantities of dairy proteins products sold and a decline in potash sales to an Israeli customer facing operational difficulties due to new local regulation.
| Operating expenses analysis | \$ millions | |||
|---|---|---|---|---|
| Total operating expenses Q2 2016 | 1,228 | |||
| Quantity | (15) | |||
| Exchange rate | (5) | |||
| Raw materials | (6) | |||
| Transportation | - | |||
| Operational costs | (36) | |||
| Other | 12 | |||
| Total operating expenses Q2 2017 | 1,178 |
| Adjusted operating income analysis | \$ millions | ||
|---|---|---|---|
| Total adjusted operating income Q2 2016 | 163 | ||
| Quantity | (6) | ||
| Price | (17) | ||
| Exchange rate | (12) | ||
| Raw materials | 6 | ||
| Transportation | - | ||
| Operational costs | 31 | ||
| Other | (12) | ||
| Total adjusted operating income Q2 2017 | 153 |
* See also 'Adjustments to reported operating and net income' table above.
The net financing expenses in the second quarter of 2017 amounted to \$49 million, compared with \$40 million in the corresponding quarter last year – an increase of \$9 million. The increase includes an increase of about \$31 million deriving mainly from fees paid with respect to early repayment of a long-term loan in the amount of about \$13 million, and from exchange rate differences relating to provisions for employee benefits in the amount of about \$13 million. On the other hand, there was a decrease in the financing expenses, in the amount of about \$22 million, deriving from an increase in income in respect of changes in the fair value of transactions hedging foreign currency, energy and marine shipping, net, partly offset by revaluation of the net liabilities.
The tax expenses in the second quarter of 2017 amounted to \$41 million, reflecting an effective tax rate of about 43%. The higher tax rate we see in 2017 is mainly due to an increase in the on-going Israeli effective tax rate on our Israeli operations. In addition the upward revaluation of the shekel against the dollar had an impact on our tax expenses. The lower than usual effective tax rate in the corresponding quarter last year was mainly due to recognition of deferred tax assets in the amount of \$27 million.
Sales
| Sales analysis | \$ millions | ||
|---|---|---|---|
| Total sales YTD 2016 | 2,642 | ||
| Quantity | 95 | ||
| Price | (74) | ||
| Exchange rate | (46) | ||
| Total sales YTD 2017 | 2,617 |
The following table sets forth sales by geographical regions based on the location of the customer:
| 1-6/2017 | 1-6/2016 | |||
|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
|
| Europe | 991 | 38 | 1,039 | 39 |
| Asia | 607 | 23 | 559 | 21 |
| North America | 570 | 22 | 549 | 21 |
| South America | 292 | 11 | 269 | 10 |
| Rest of the world | 157 | 6 | 226 | 9 |
| Total | 2,617 | 100 | 2,642 | 100 |
The breakdown of the sales in the six months ended June 30, 2017 shows a decrease in sales to Europe, deriving mainly from a decline in quantities and selling prices of potash, a decline in phosphate fertilizers selling prices together with a decline in the quantities of phosphate rock sold. This decrease was partly offset by an increase in ICL Specialty Solutions segment products, mainly clear brine solutions, acids and P2S5. The increase in sales to Asia derives mainly from an increase in the quantities sold of potash, phosphoric acid, dairy proteins, acids and specialty agriculture products. This increase was partly offset by a decrease in phosphate fertilizers selling prices and in phosphate rock quantities sold. The increase in sales to North America derives mainly from an increase in the quantities and selling prices of potash together with an increase in clear brines solutions and phosphate fertilizers quantities sold. The increase in sales to South America derives mainly from an increase in potash selling prices and quantities sold. The decrease in sales to the rest of the world derives mainly from a decrease in the quantities of dairy proteins products sold and a decline in potash sales to an Israeli customer facing operational difficulties due to new local regulation.
| Operating expenses analysis | \$ millions 2,386 |
||
|---|---|---|---|
| Total operating expenses YTD 2016 | |||
| Quantity | 61 | ||
| Exchange rate | (27) | ||
| Raw materials | (33) | ||
| Transportation | 23 | ||
| Operational costs | (48) | ||
| Other | (5) | ||
| Total operating expenses YTD 2017 | 2,357 |
| Adjusted operating income analysis | \$ millions | |
|---|---|---|
| Total adjusted operating income YTD 2016 | 278 | |
| Quantity | 34 | |
| Price | (74) | |
| Exchange rate | (19) | |
| Raw materials | 33 | |
| Transportation | (23) | |
| Operational costs | 35 | |
| Other | 5 | |
| Total adjusted operating income YTD 2017 | 269 |
* See also 'Adjustments to reported operating and net income' table above.
The net financing expenses in the six months ended June 30, 2017 amounted to \$63 million, compared with \$68 million in the corresponding period last year – a decrease of \$5 million. The decrease includes a decline of about \$38 million deriving from an increase in income in respect of changes in the fair value of transactions hedging foreign currency, energy and marine shipping, net, partly offset by revaluation of the net liabilities. On the other hand, there was an increase in the financing expenses, in the amount of about \$33 million, deriving mainly from fees paid with respect to early repayment of long-term loans in the amount of about \$13 million, and from exchange rate differences relating to provisions for employee benefits in the amount of about \$15 million.
The tax expenses in the six months ended June 30, 2017 amounted to \$83 million reflecting an effective tax rate of about 42%. The higher tax rate we see in 2017 is mainly due to an increase in the on-going Israeli effective tax rate on our Israeli operations. In addition the upward revaluation of the shekel against dollar had an impact on our tax expenses. The lower than usual effective tax rate in the corresponding period last year was mainly due to recognition of deferred tax assets in the amount of \$27 million.
Segment revenues, expenses and results include inter-segment transfers, which are priced based on transaction prices in the ordinary course of business. These transfers are eliminated as part of consolidation of the financial statements. The segment income is measured based on the operating income, without certain expenses that are not allocated to the operating segments including general and administrative expenses, as it is included in reports that are regularly reviewed by the chief operating decision maker.
This segment includes three business lines: ICL Industrial Products, ICL Advanced Additives and ICL Food Specialties. The segment targets industrial markets and concentrates on achieving growth through a highly-tailored customer focus, product innovation and commercial excellence.
Significant highlights and business environment
Total Advanced Additives performance was favorable compared to the corresponding quarter last year and was impacted by several factors:
ICL Food Specialties' phosphates business remained under pressure as the competitive business environment in North America and Europe was only partly offset by a recovery in sales in South America. The price increases in North America announced during the quarter had a favorable impact on the quarter's revenues, and are expected to have a further positive impact during the second half of the year. Sales volumes in Europe were flat compared to the corresponding quarter last year, while sales in Russia decreased due to a transition process to a new distributor.
Sales volumes of integrated solutions and new products have continued to grow consecutively and year over year as the business line continues to launch new products globally. Moreover, increased orders during the quarter are adding to the positive outlook for the rest of 2017.
| 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 | |
|---|---|---|---|---|---|
| \$ millions |
\$ millions |
\$ millions |
\$ millions |
\$ millions |
|
| Industrial Products | 291 | 294 | 601 | 562 | 1,120 |
| Sales to external customers | 287 | 292 | 595 | 559 | 1,111 |
| Sales to internal customers | 4 | 2 | 6 | 3 | 9 |
| Advanced Additives | 208 | 206 | 377 | 369 | 798 |
| Sales to external customers | 195 | 193 | 350 | 337 | 732 |
| Sales to internal customers | 13 | 13 | 27 | 32 | 66 |
| Food Specialties | 147 | 174 | 285 | 336 | 659 |
| Sales to external customers | 143 | 170 | 279 | 329 | 650 |
| Sales to internal customers | 4 | 4 | 6 | 7 | 9 |
| Setoffs | (6) | (7) | (10) | (16) | (24) |
| Total segment sales | 640 | 667 | 1,253 | 1,251 | 2,553 |
| Operating income | 135 | 136 | 250 | 242 | 534 |
* Following internal business alignment, the Specialty Solutions segment sales include revenues for the Specialty Minerals subbusiness line as part of ICL Industrial Products, which were presented in ICL Advanced Additives in prior periods.
| Sales analysis | Industrial Products |
Advanced Additives |
Food Specialties |
Setoff | Segment Total |
|
|---|---|---|---|---|---|---|
| \$ millions | ||||||
| Total sales Q2 2016 | 294 | 206 | 174 | (7) | 667 | |
| Quantity | (3) | 8 | (26) | 1 | (20) | |
| Price | 2 | (3) | - | (1) | (2) | |
| Exchange rate | (2) | (3) | (1) | 1 | (5) | |
| Total sales Q2 2017 | 291 | 208 | 147 | (6) | 640 |
Quantity – the decrease derives mainly from the decrease in dairy protein quantities sold in ICL Food Specialties (which was slightly offset by an increase in quantities of new products sold). This decrease was partly offset by an increase in quantities sold in the acids sub-business line of ICL Advanced Additives. See also 'Significant highlights and business environment' section.
Exchange rate – the decrease derives mainly from devaluation of the euro against the dollar compared to the corresponding quarter last year.
| Operating income analysis | \$ millions | |
|---|---|---|
| Total operating income Q2 2016 | 136 | |
| Quantity | - | |
| Price | (2) | |
| Exchange rate | (6) | |
| Raw materials | 6 | |
| Transportation | 1 | |
| Other | - | |
| Total operating income Q2 2017 | 135 |
Quantity – in ICL Advanced Additives there was an increase deriving from the acids sub-business line which was fully offset by the decrease in the dairy proteins sub-business line in ICL Food Specialties.
Price – the decrease derives from lower selling prices of acids in ICL Advanced Additives.
Exchange rate – the decrease derives mainly from devaluation of the euro against the dollar which decreased revenues, coupled with the upward revaluation of the shekel against the dollar, which increased production costs.
Raw materials – the increase derives mainly from a decrease in sulfur prices used for products of ICL Advanced Additives.
- Price – the decrease derives from lower selling prices of acids in ICL Advanced Additives.
| Sales analysis | Industrial Products |
Advanced Additives |
Food Specialties |
Setoff | Segment Total |
|
|---|---|---|---|---|---|---|
| Total sales YTD 2016 | 562 | 369 | \$ millions 336 |
(16) | 1,251 | |
| Quantity | 48 | 25 | (45) | 6 | 34 | |
| Price | (7) | (10) | (1) | 1 | (17) | |
| Exchange rate | (2) | (7) | (5) | (1) | (15) | |
| Total sales YTD 2017 | 601 | 377 | 285 | (10) | 1,253 |
Quantity – the increase derives mainly from an increase in sales of clear brine solutions quantities, together with bromine-based flame retardants and elemental bromine in ICL Industrial Products and from an increase in quantities sold in the acids and P2S5 sub-business lines of ICL Advanced Additives. This increase was partly offset by the decrease in dairy proteins quantities sold in ICL Food Specialties (which was slightly offset by an increase in quantities of new products sold). See also 'Significant highlights and business environment' section.
Price the decrease derives mainly from a decrease in the selling prices of acids in ICL Advanced Additives and the products mix of clear brine solutions sold in ICL Industrial Products.
Specialty Solutions Segment information as at June 30, 2017 (Unaudited)
| Operating income analysis | \$ millions | ||
|---|---|---|---|
| Total operating income YTD 2016 | 242 | ||
| Quantity | 35 | ||
| Price | (17) | ||
| Exchange rate | (12) | ||
| Raw materials | 14 | ||
| Transportation | - | ||
| Other | (12) | ||
| Total operating income YTD 2017 | 250 |
This segment includes three business lines: ICL Potash & Magnesium, ICL Phosphate and ICL Specialty Fertilizers. The segment targets the Agro markets and focuses on efficiency, process innovation and operational excellence.
Potash imports into India during the first half of 2017 amounted to 2.187 million tonnes, a 78% increase over the corresponding period last year. The sharp increase derives from the importers' projection of higher prices in the 2017/2018 contract and the 20% (about \$28 per tonne) reduction of the NBS (Nutrient Based Subsidy) during the 2017/2018 fiscal year (starting April 1, 2017). The reduction of the NBS may impose an additional challenge to the sales of potash to local farmers. However, the potash to nitrogen fertilizer ratio (K to N) in India is already considered very low, hence a further reduction in that ratio could have an adverse effect on yields. Therefore, we don't anticipate a significant decline in demand for potash. During the second quarter of 2017, ICL continued its potash deliveries under the 2016 supply contracts, which ended in June 2017.
Demand for potash in Brazil was particularly strong. According to ANDA (Brazilian National Fertilizer Association), potash imports into Brazil during the first half of 2017 amounted to 4.3 million tonnes, a 10% increase over the corresponding period last year. Although imports are high, local sales are slightly lower, and inventories are on the rise.
Brazilian imports of phosphate fertilizers (MAP, DAP, TSP & SSP) during the first half of 2017 amounted to 2.642 million tonnes, a 26.6% increase over the corresponding period last year. The increase is attributable mainly to higher planted areas of soybeans and improvement in farmers' profitability. The MAP CFR Brazil price in the first half of 2017 was stable to firm, with a moderate decline in July. At an average price of \$355 CFR, July 2017 price is practically equal to the average price in the third quarter of 2016. The TSP CFR Brazil price in July 2017 is just 1% below the price in the third quarter of 2016.
The United States phosphate market is between the spring season and the summer fill for the next fall season. DAP imports in January to May 2017 amounted to about 396 thousand tonnes compared to about 302 thousand tonnes in the corresponding period last year. MAP imports amounted to about 490 thousand tonnes compared to about 410 thousand tonnes in the corresponding period last year. Despite the pressure on phosphate prices, most markets west of the Suez are showing stability.
The Company is taking action to explore solutions for, among other things, restoration of the ponds in the short- and long-term and to rectify any environmental harm caused, to the extent required. The Company's actions are being carried out in full coordination and close cooperation with the Israeli environmental authorities, including the Ministry of Environmental Protection and the Nature and National Parks Authority. The Company is committed to environmental responsibility, and for years has worked closely with the Israeli's environmental authorities to maintain the Negev's natural reserves in the area of its facilities. For further information, including the applications for class action claims, see Note 6 to the Company's condensed consolidated interim financial statements as at June 30, 2017.
During the second quarter, the business line was negatively impacted by the Israeli ammonia shortage, which led to lower sales and profitability of ammonia-based products in Israel and out of Israel (mainly in North America).
Higher demand in the ornamental horticulture markets, mainly in the European and Asia Pacific regions, drove an increase in sales and margins compared to the corresponding quarter in 2016, which was partially offset by a decrease in sales to North America, mainly in coated fertilizers.
Results of Operations - Essential Minerals Segment
| 2016 | |||||
|---|---|---|---|---|---|
| \$ | \$ | \$ | \$ | \$ millions |
|
| 1,338 | |||||
| 1,213 | |||||
| 35 | 36 | 65 | 68 | 125 | |
| 1,163 | |||||
| 966 | |||||
| 44 | 57 | 89 | 107 | 197 | |
| 661 | |||||
| 632 | |||||
| 2 | 5 | 8 | 13 | 29 | |
| (32) | (42) | (65) | (79) | (126) | |
| 736 | 765 | 1,470 | 1,488 | 3,036 | |
| 81 | 113 | 147 | 206 | 398 | |
| 4-6/2017 millions 314 279 264 220 190 188 |
4-6/2016 millions 299 263 319 262 189 184 |
1-6/2017 millions 597 532 556 467 382 374 |
1-6/2016 millions 572 504 618 511 377 364 |
For additional details regarding potash – see 'Potash – Stand-Alone Activities'.
| Sales analysis | Potash & Magnesium |
Phosphate | Specialty Fertilizers |
Setoff | Segment Total |
|
|---|---|---|---|---|---|---|
| \$ millions | ||||||
| Total sales Q2 2016 | 299 | 319 | 189 | (42) | 765 | |
| Quantity | 20 | (38) | 7 | 7 | (4) | |
| Price | (3) | (11) | (4) | 3 | (15) | |
| Exchange rate | (2) | (6) | (2) | - | (10) | |
| Total sales Q2 2017 | 314 | 264 | 190 | (32) | 736 |
Quantity – the decrease derives mainly from a decline in phosphate fertilizers and phosphate rock quantities sold, which was partly offset by an increase in potash sales (mainly to Asia and South America) and an increase in the quantities of ICL Specialty Fertilizers products sold.
Price – the decrease derives mainly from a decline in phosphate fertilizers and phosphoric acid selling prices, lower prices of commodity fertilizers and a decline in potash and magnesium selling prices.
Exchange rate – the decrease derives mainly from the devaluation of the euro, the Chinese yuan and the pound against the dollar compared to the corresponding quarter last year.
| Operating income analysis | \$ millions |
|---|---|
| Total operating income Q2 2016 | 113 |
| Quantity | 2 |
| Price | (15) |
| Exchange rate | (6) |
| Raw materials | 2 |
| Transportation | (1) |
| Other | (14) |
| Total operating income Q2 2017 | 81 |
| Sales analysis | Potash & Magnesium |
Phosphate | Specialty Fertilizers |
Setoff | Segment Total |
|
|---|---|---|---|---|---|---|
| Total sales YTD 2016 | 572 | 618 | 377 | (79) | 1,488 | |
| Quantity | 44 | (3) | 22 | 9 | 72 | |
| Price | (9) | (47) | (11) | 6 | (61) | |
| Exchange rate | (10) | (12) | (6) | (1) | (29) | |
| Total sales YTD 2017 | 597 | 556 | 382 | (65) | 1,470 |
Quantity – the increase derives mainly from an increase in potash sales (mainly to Asia, North and South America) and from an increase in the quantities of specialty agriculture products sold to Asia and Europe.
Price – the decrease derives mainly from a decline in phosphate fertilizers and phosphoric acid selling prices, lower prices of commodity fertilizers and a decline in potash and magnesium selling prices.
Exchange rate – the decrease derives mainly from the devaluation of the euro, the Chinese yuan and the pound against the dollar compared to the corresponding period last year.
| \$ millions | |||
|---|---|---|---|
| 206 | |||
| 13 | |||
| (61) | |||
| (9) | |||
| 22 | |||
| (23) | |||
| (1) | |||
| 147 | |||
| Thousands of Tonnes | 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 |
|---|---|---|---|---|---|
| Phosphate rock | |||||
| Production of rock | 1,284 | 1,553 | 2,683 | 2,894 | 5,744 |
| Sales * | 83 | 195 | 242 | 558 | 1,032 |
| Phosphate rock used for internal purposes | 1,088 | 1,116 | 2,184 | 1,867 | 4,099 |
| Phosphate fertilizers | |||||
| Production | 479 | 586 | 1,049 | 1,158 | 2,725 |
| Sales * | 577 | 713 | 1,226 | 1,218 | 2,645 |
* To external customers.
| Millions of dollars | 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 |
|---|---|---|---|---|---|
| Average potash selling price per tonne - FOB (in \$) | 216 | 221 | 216 | 225 | 211 |
| Sales to external customers | 261 | 242 | 492 | 463 | 1,134 |
| Sales to internal customers * | 41 | 43 | 78 | 83 | 151 |
| Total Sales | 302 | 285 | 570 | 546 | 1,285 |
| Gross Profit | 125 | 112 | 209 | 199 | 513 |
| Operating income | 65 | 65 | 106 | 116 | 291 |
* Sales to other business lines of ICL including the Magnesium business.
The potash stand-alone activities include, among others, polysulphate produced in a mine in the UK and salt produced in underground mines in UK and Spain.
| Sales analysis | \$ millions | ||
|---|---|---|---|
| Total sales Q2 2016 | 285 | ||
| Quantity | 20 | ||
| Price | (1) | ||
| Exchange rate | (2) | ||
| Total sales Q2 2017 | 302 |
| Operating income | \$ millions 65 |
||
|---|---|---|---|
| Total operating income Q2 2016 | |||
| Quantity | 12 | ||
| Price | (1) | ||
| Exchange rate | - | ||
| Raw materials | - | ||
| Transportation | (8) | ||
| Other | (3) | ||
| Total operating income Q2 2017 | 65 |
Quantity – the increase derives from potash sales mainly to Asia and South America.
Transportation – the decrease derives mainly from an increase in transportation prices and an increase in quantities of potash sold.
| Sales analysis | \$ millions | ||
|---|---|---|---|
| Total sales YTD 2016 | 546 | ||
| Quantity | 39 | ||
| Price | (6) | ||
| Exchange rate | (10) | ||
| Total sales YTD 2017 | 569 |
| Operating income analysis | \$ millions | |||
|---|---|---|---|---|
| Total operating income YTD 2016 | 116 | |||
| Quantity | 18 | |||
| Price | (6) | |||
| Exchange rate | 1 | |||
| Raw materials | - | |||
| Transportation | (22) | |||
| Other | (1) | |||
| Total operating income YTD 2017 | 106 |
Quantity – the increase derives from potash sales mainly to Asia, North and South America.
Price – the decrease derives from a decline in potash selling prices.
Transportation – the decrease derives mainly from an increase in transportation prices and an increase in quantities of potash sold.
| Thousands of Tonnes | 4-6/2017 | 4-6/2016 | 1-6/2017 | 1-6/2016 | 2016 |
|---|---|---|---|---|---|
| Production | 1,232 | 1,363 | 2,289 | 2,711 | 5,279 |
| Sales to external customers | 1,051 | 1,010 | 1,993 | 1,893 | 4,818 |
| Sales to internal customers | 80 | 114 | 152 | 148 | 347 |
| Total sales (including internal sales) | 1,131 | 1,124 | 2,145 | 2,041 | 5,165 |
| Closing inventory | 810 | 1,222 | 810 | 1,222 | 666 |
Net cash provided by operating activities:
In the second quarter of 2017, the cash flows provided by operating activities decreased by \$39 million compared with the corresponding quarter last year. This decrease derives mainly from a decline in the net income and a decline in the working capital in the corresponding quarter last year, due to an increase in phosphate sales in China, which was accompanied by a decrease in inventories.
In the second quarter of 2017, the cash flows used in investing activities decreased compared with the corresponding quarter last year, by \$13 million. This decrease derives mainly from a decrease in the cash flows used for investments in property, plant and equipment, and other assets, in the amount of \$41 million. The decrease was mostly offset by an increase in deposits.
In the second quarter of 2017, there was an increase of \$10 million in the cash flows used in financing activities compared with the corresponding quarter last year. This increase derives mainly from repayment of long-term loans net of long-term loans received, in the amount of \$125 million, compared with receipt of net long-term loans, in the amount of \$141 million, in the corresponding quarter last year. The increase was partly offset due to a receipt of short-term credit from banks and others, net, in the amount of \$152 million, compared with repayment of short-term credit from banks and others, net, in the amount of \$91 million, in the corresponding quarter last year.
As at June 30, 2017, the net financial liabilities of ICL amounted to \$3,300 million, an increase of \$32 million compared with the balance at the end of 2016. The increase of the net financial liabilities derives mostly from dividend payments in the amount of \$149 million and from the exchange rate impact, which were partially offset by the operating cash flow generated during the first six months of 2017.
The total amount of the securitization framework and credit facility deriving therefrom amounts to \$405 million. As at June 30, 2017, ICL had used \$311 million of the securitization facility.
ICL also has long-term credit facilities of \$2,026 million and €100 million, of which \$1,335 million was unutilized as at June 30, 2017.
As the date of the report, the Company is in compliance with the financial covenants stipulated in its financing agreements.
There were no material changes in our critical accounting estimates during the six-month period ended June 30, 2017.
In the six-month period ended June 30, 2017, there were no material changes in the risk factors previously disclosed in our Annual Report on Form 20-F for the year ended December 31, 2016.
Reference is made to "Item 11 – Quantitative and Qualitative Disclosures about Market Risks" in our Annual Report on Form 20-F for the year ended December 31, 2016.
Pursuant to the resolution of ICL's Board dated December 15, 2016, the Company appointed a special independent external committee (the "Special Committee") to examine all aspects arising from the application for certification of a derivative action regarding the annual bonuses paid to office holders for the years 2014-2015 (the "Certification Application"). The Hon. Judge (ret.) Oded Mudrick was appointed to head the Special Committee and the Special Committees' other members are: Prof. Sharon Hannes and Prof. Haim Assayag, CPA. For purposes of its operations, the Special Committee appointed a legal advisor to accompany its work – Dr. Asaf Eckstein.
On April 18, 2017 the Special Committee submitted its report to the Board of Directors, wherein it determined, among other things, that in its opinion the adjustments to the net profit as approved by the Company's Compensation Committee for the years 2014 and 2015 were duly made and in accordance with the Company's compensation policy. Therefore, the Company does not have a cause of action against the directors who approved the bonus adjustments for the years 2014 and 2015, or against the officers who received the bonuses due to the said adjustments. In light of the foregoing, it would be improper for the Company to demand any restitution or reparation due to the events specified in the Certification Application filed by the Applicant. Accordingly, the Committee recommended that the Company oppose the Application filed with the Court by the Applicant.
On April 26, 2017, the Company's Board resolved to fully adopt the Special Committee's report and the recommendation therein to deny the Applicant's demand in the Certification Application and to instruct the Company to file an objection to the Certification Application.
On May 11, 2017, the Applicant applied to Court, arguing that the Company is not permitted to attach the Special Committee's report to its response. On June 6, 2017, the Company and the remaining respondents submitted its response to the Certification Application. For cautionary purposes the Special Committee's report was not attached to the Company's response,; however as part of the Company's response the Court was requested to allow submission of the Special Committee's report.
In accordance with the Court's decision, the date for submission of the Applicant's reply to the responses of the Company and the other respondents to the Certification Application was set as September 24, 2017.
Further to Note 13 of the 2016 annual financial statements, and according to the announcement issued by the Company on May 10, 2017, ICL Europe Coöperatief U.A. ("ICL Europe"), a subsidiary of the Company, filed a claim under the Bilateral Investment Treaty (BIT) against the Federal Democratic Republic of Ethiopia ("Ethiopia") in relation to State violations of the Agreement on Encouragement and Reciprocal Protection of Investments between the Ethiopia and the Netherlands. The violations relate to, inter alia, the State's imposition of an illegal tax assessment against, and its failure to provide infrastructure support to, Allana Potash Afar Plc, a second-tier subsidiary of ICL Europe. ICL Europe filed the claim under the Arbitration Rules of the United Nations Commission on International Trade Law (UNCITRAL), and requested the Permanent Court of Arbitration at The Hague to administer the arbitration proceedings. On June 12, 2017, Ethiopia filed its response to the notice of arbitration. As at the date of the report, the Company has a full tax provision in respect of the said tax assessment.
For further information regarding legal proceedings and other contingencies, see Note 6 to the Company's condensed consolidated interim financial statements as at June 30, 2017.
On June 22, 2017, the Company announced that as part of its plan for generating available sources for financing additional investments, as well as to reduce its current leverage level, it is exploring, among other things, various opportunities to divest subsidiaries and/or assets that have a low synergy profile with ICL's mineral chain and/or portfolio, in the amount of about \$500 million or more. In the framework of the said plan, the Company signed an agreement for sale of its holdings in IDE Technologies Ltd., constituting 50% of IDE's share capital, in exchange for a consideration of about \$178 million. For additional details regarding the sale transaction – see Note 6 to the Company's condensed consolidated interim financial statements as at June 30, 2017.
On July 16, 2017, the Company gave notice with respect to negotiations being carried on in connection with formulation of a non-binding memorandum of understanding with Energean Israel Limited (hereinafter – "Energean"), a holder of interests in the Karish and Tanin gas fields (hereinafter – the "Gas Field"), which after its signing (to the extent it is approved by all the competent authorities) will constitute the basis for negotiations that will be carried on between the parties, in contemplation of signing a detailed and binding agreement for supply of natural gas (if signed), under which the Company will purchase natural gas in the quantities and for the periods as will be agreed upon therein, for purposes of running the power plant in Sodom and the Company's other facilities in Israel.
The highlights of the matters included in the memorandum of understanding are as follows: (A) the total quantity of gas the Company is anticipated to purchase from Energean is about 13 BCM with respect to the entire expected supply period (hereinafter – "the Total Contractual Quantity"); (B) the supply period will commence on the date on which Energean commences operation of the Gas Field, and is expected to end on the earlier of the date on which the Total Contractual Quantity is consumed or after the passage of 15 years from the commencement date of supply of the natural gas to the Company; (C) a "take or pay" payment mechanism for a minimum annual quantity of natural gas in the amount and according to the mechanism that will be determined; and (D) the price of the natural gas will be linked to the electricity generation component and will include a minimum price.
The negotiations with Energean were conducted jointly by the Company, Oil Refineries Ltd. (a public company controlled by Israel Corporation Ltd., the Company's controlling shareholder, which is controlled (directly and indirectly) by Mr. Idan Ofer) and OPC Rotem Ltd. (a private company that is controlled indirectly by one of the Company's controlling shareholders) (hereinafter – "the Purchasers"). The Company's signing of the memorandum of understanding will require approval by the Company's authorized organs and is also subject to the signing by each of the other two Purchasers of separate memorandums of understanding with Energean. To the best of the Company's knowledge, memorandums of understanding have not yet been signed between any of the Purchasers and Energean. If and to the extent signed, only a non-binding memorandum of understanding is involved, and signing of an agreement for supply of the gas and the actual supply of the gas in accordance therewith are subject to, among other things, completion of the negotiations, signing a binding agreement, and meeting various milestones and preconditions, including arrangement and supply of natural gas to the Company in a case where the Gas Field is ultimately not developed. A binding agreement, if and to the extent signed, will require proper approval by the Company's authorized organs.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
By: /s/ Kobi Altman Name: Kobi Altman Title: Chief Financial Officer
By: /s/ Lisa Haimovitz
Name: Lisa Haimovitz Title: Senior Vice President, Global General Counsel and Corporate Secretary
Date: August 3, 2017
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.